Retatrutide
A next-generation, triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors. Engineered for laboratory studies of metabolic pathways, appetite regulation, and lipid metabolism.
Choose your plan
Choose your dosage
Specifications
| Purity | ≥99% |
|---|---|
| Form | Lyophilized Powder |
| Storage | Store at -20°C |
Description
Retatrutide is a next-generation, triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors. Engineered for laboratory studies of metabolic pathways, appetite regulation, and lipid metabolism. Each batch is independently tested and supplied with full COA documentation.
Available Quantities
100mg
Key Specifications
Form: Lyophilized powder
Molecular Formula: C221H342N54O68
Molecular Weight: ~4731.33 g/mol
Purity: ≥99% (HPLC Verified)
Sequence: Triple-receptor agonist (GLP-1, GIP, and GCGR)
All products are sold for research and laboratory use only. Not for human or animal consumption. Not for diagnostic or therapeutic use.